Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 88

    1.

    Ranirestat for the management of diabetic sensorimotor polyneuropathy.

    Bril V, Hirose T, Tomioka S, Buchanan R; Ranirestat Study Group.

    Diabetes Care. 2009 Jul;32(7):1256-60. Epub 2009 Apr 14.PMID: 19366965 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study.

    Merkies IS, Bril V, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Latov N, van Doorn PA; ICE Study Group.

    Neurology. 2009 Apr 14;72(15):1337-44.PMID: 19365055 [PubMed - indexed for MEDLINE]Related articles

    3.

    Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy.

    Bril V, Tomioka S, Buchanan RA, Perkins BA; mTCNS Study Group.

    Diabet Med. 2009 Mar;26(3):240-6.PMID: 19317818 [PubMed - indexed for MEDLINE]Related articles

    4.

    Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.

    Bril V, Katzberg H, Donofrio P, Banach M, Dalakas MC, Deng C, Hanna K, Hartung HP, Hughes RA, Latov N, Merkies IS, van Doorn PA; ICE Study Group.

    Muscle Nerve. 2009 Apr;39(4):448-55.PMID: 19260050 [PubMed - indexed for MEDLINE]Related articles

    5.

    Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux.

    Matsumoto T, Ono Y, Kurono M, Kuromiya A, Nakamura K, Bril V.

    J Pharmacol Sci. 2009 Feb;109(2):203-10. Epub 2009 Feb 10.PMID: 19212096 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocin-diabetic rats.

    Matsumoto T, Ono Y, Kurono M, Kuromiya A, Nakamura K, Bril V.

    J Pharmacol Sci. 2008 Jul;107(3):231-7.PMID: 18635918 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Long-term treatment with ranirestat (AS-3201), a potent aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats.

    Matsumoto T, Ono Y, Kuromiya A, Toyosawa K, Ueda Y, Bril V.

    J Pharmacol Sci. 2008 Jul;107(3):340-8. Epub 2008 Jul 8.PMID: 18612195 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.

    Zinman L, Bril V.

    Ann N Y Acad Sci. 2008;1132:264-70.PMID: 18567877 [PubMed - indexed for MEDLINE]Related articles

    9.

    A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.

    Jensen P, Bril V.

    J Clin Neuromuscul Dis. 2008 Mar;9(3):352-5.PMID: 18344718 [PubMed - indexed for MEDLINE]Related articles

    10.

    Diagnostic tools for diabetic sensorimotor polyneuropathy.

    Kles KA, Bril V.

    Curr Diabetes Rev. 2006 Aug;2(3):353-61. Review.PMID: 18220640 [PubMed - indexed for MEDLINE]Related articles

    11.

    Emerging therapies for diabetic neuropathy: a clinical overview.

    Perkins BA, Bril V.

    Curr Diabetes Rev. 2005 Aug;1(3):271-80. Review.PMID: 18220603 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial.

    Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, Hartung HP, Latov N, Merkies IS, van Doorn PA; ICE Study Group.

    Lancet Neurol. 2008 Feb;7(2):136-44. Erratum in: Lancet Neurol. 2008 Sep;7(9):771. PMID: 18178525 [PubMed - indexed for MEDLINE]Related articles

    13.

    Multi-site testing with a point-of-care nerve conduction device can be used in an algorithm to diagnose diabetic sensorimotor polyneuropathy.

    Perkins BA, Orszag A, Grewal J, Ng E, Ngo M, Bril V.

    Diabetes Care. 2008 Mar;31(3):522-4. Epub 2007 Dec 10.PMID: 18070992 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Neuromuscular function in survivors of the acute respiratory distress syndrome.

    Angel MJ, Bril V, Shannon P, Herridge MS.

    Can J Neurol Sci. 2007 Nov;34(4):427-32.PMID: 18062450 [PubMed - indexed for MEDLINE]Related articles

    15.

    Surrogate therapeutic outcome measures in patients with myasthenia gravis.

    Zinman L, Baryshnik D, Bril V.

    Muscle Nerve. 2008 Feb;37(2):172-6.PMID: 17918748 [PubMed - indexed for MEDLINE]Related articles

    16.

    Muscle and nerve involvement in granulomatous mycosis fungoides.

    Hazrati LN, Bril V, Nag S.

    Muscle Nerve. 2007 Dec;36(6):860-5.PMID: 17487868 [PubMed - indexed for MEDLINE]Related articles

    17.

    Guidelines on the use of intravenous immune globulin for neurologic conditions.

    Feasby T, Banwell B, Benstead T, Bril V, Brouwers M, Freedman M, Hahn A, Hume H, Freedman J, Pi D, Wadsworth L.

    Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S57-107.PMID: 17397768 [PubMed - indexed for MEDLINE]Related articles

    18.

    IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial.

    Zinman L, Ng E, Bril V.

    Neurology. 2007 Mar 13;68(11):837-41.PMID: 17353471 [PubMed - indexed for MEDLINE]Related articles

    19.

    Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.

    Perkins BA, Grewal J, Ng E, Ngo M, Bril V.

    Diabetes Care. 2006 Sep;29(9):2023-7.PMID: 16936147 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Diagnosis and Treatment of Chronic Immune-mediated Neuropathies.

    Latov N, Gorson KC, Brannagan TH 3rd, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJ, England JD, Fisher MA, Herrmann DN, Menkes DL, Sahenk Z, Sander HW, Triggs WJ, Vallat JM.

    J Clin Neuromuscul Dis. 2006 Mar;7(3):141-157.PMID: 19078800 [PubMed - as supplied by publisher]Related articles

    21.

    Objective evidence for the reversibility of nerve injury in diabetic neuropathic cachexia.

    Grewal J, Bril V, Lewis GF, Perkins BA.

    Diabetes Care. 2006 Feb;29(2):473-4. No abstract available. Erratum in: Diabetes Care. 2006 Sep;29(9):2185. Lewis, Gary [corrected to Lewis, Gary F]. PMID: 16443922 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Sensitivity of repetitive facial-nerve stimulation in patients with myasthenia gravis.

    Zinman LH, O'Connor PW, Dadson KE, Leung RC, Ngo M, Bril V.

    Muscle Nerve. 2006 May;33(5):694-6.PMID: 16421884 [PubMed - indexed for MEDLINE]Related articles

    23.
    24.

    A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy.

    Zinman LH, Sutton D, Ng E, Nwe P, Ngo M, Bril V.

    Transfus Apher Sci. 2005 Nov;33(3):317-24. Epub 2005 Oct 18.PMID: 16239123 [PubMed - indexed for MEDLINE]Related articles

    25.

    Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.

    Bastyr EJ 3rd, Price KL, Bril V; MBBQ Study Group.

    Clin Ther. 2005 Aug;27(8):1278-94.PMID: 16199253 [PubMed - indexed for MEDLINE]Related articles

    26.

    Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial.

    Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

    Clin Ther. 2005 Aug;27(8):1164-80.PMID: 16199243 [PubMed - indexed for MEDLINE]Related articles

    27.

    Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy.

    Vinik AI, Bril V, Litchy WJ, Price KL, Bastyr EJ 3rd; MBBQ Study Group.

    Muscle Nerve. 2005 Nov;32(5):619-25.PMID: 16116628 [PubMed - indexed for MEDLINE]Related articles

    28.

    Hyaline body myopathy: adulthood manifestations.

    Rafay MF, Halliday W, Bril V.

    Can J Neurol Sci. 2005 May;32(2):253-6.PMID: 16018165 [PubMed - indexed for MEDLINE]Related articles

    29.

    Diabetic neuropathies: a statement by the American Diabetes Association.

    Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D; American Diabetes Association.

    Diabetes Care. 2005 Apr;28(4):956-62. Review. No abstract available. PMID: 15793206 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    A comparison of electrodiagnostic tests in ocular myasthenia gravis.

    Katzberg HD, Bril V.

    J Clin Neuromuscul Dis. 2005 Mar;6(3):109-13.PMID: 19078758 [PubMed - in process]Related articles

    31.

    Early vascular risk factor modification in type 1 diabetes.

    Perkins BA, Bril V.

    N Engl J Med. 2005 Jan 27;352(4):408-9. No abstract available. Erratum in: N Engl J Med. 2005 Mar 3;352(9):950. PMID: 15673807 [PubMed - indexed for MEDLINE]Related articles

    32.

    Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.

    Bril V, Buchanan RA.

    Diabetes Care. 2004 Oct;27(10):2369-75.PMID: 15451902 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments.

    Zinman LH, Bril V, Perkins BA.

    Diabetes Care. 2004 Jul;27(7):1674-9.PMID: 15220245 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Sural nerve sorbitol in patients with diabetic sensorimotor polyneuropathy.

    Bril V, Ono Y, Buchanan RA.

    Diabetes Care. 2004 May;27(5):1160-3. Review.PMID: 15111538 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Low-intensity laser therapy for painful symptoms of diabetic sensorimotor polyneuropathy: a controlled trial.

    Zinman LH, Ngo M, Ng ET, Nwe KT, Gogov S, Bril V.

    Diabetes Care. 2004 Apr;27(4):921-4.PMID: 15047649 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Carpal tunnel syndrome: cross-sectional and outcome study in Ontario workers.

    Manktelow RT, Binhammer P, Tomat LR, Bril V, Szalai JP.

    J Hand Surg Am. 2004 Mar;29(2):307-17.PMID: 15043907 [PubMed - indexed for MEDLINE]Related articles

    37.

    Impact of minimally invasive trans-cervical thymectomy on outcome in patients with myasthenia gravis.

    de Perrot M, Bril V, McRae K, Keshavjee S.

    Eur J Cardiothorac Surg. 2003 Nov;24(5):677-83.PMID: 14583297 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Diabetic neuropathy: a review emphasizing diagnostic methods.

    Perkins BA, Bril V.

    Clin Neurophysiol. 2003 Jul;114(7):1167-75. Review.PMID: 12842711 [PubMed - indexed for MEDLINE]Related articles

    39.

    Diagnosis and management of diabetic neuropathy.

    Perkins BA, Bril V.

    Curr Diab Rep. 2002 Dec;2(6):495-500. Review.PMID: 12643156 [PubMed - indexed for MEDLINE]Related articles

    40.

    Prognostic significance of thymomas in patients with myasthenia gravis.

    de Perrot M, Liu J, Bril V, McRae K, Bezjak A, Keshavjee SH.

    Ann Thorac Surg. 2002 Nov;74(5):1658-62.PMID: 12440626 [PubMed - indexed for MEDLINE]Related articles

    41.

    Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy.

    Bril V, Perkins BA.

    Diabetes Care. 2002 Nov;25(11):2048-52.PMID: 12401755 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Comparison of sensory testing on different toe surfaces: implications for neuropathy screening.

    Dimitrakoudis D, Bril V.

    Neurology. 2002 Aug 27;59(4):611-3.PMID: 12196660 [PubMed - indexed for MEDLINE]Related articles

    44.

    Carpal tunnel syndrome in patients with diabetic polyneuropathy.

    Perkins BA, Olaleye D, Bril V.

    Diabetes Care. 2002 Mar;25(3):565-9.PMID: 11874948 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy.

    Perkins BA, Ngo M, Bril V.

    Muscle Nerve. 2002 Feb;25(2):212-7.PMID: 11870689 [PubMed - indexed for MEDLINE]Related articles

    46.

    Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.

    Olaleye D, Perkins BA, Bril V.

    Diabetes Res Clin Pract. 2001 Nov;54(2):115-28.PMID: 11640995 [PubMed - indexed for MEDLINE]Related articles

    47.

    Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.

    Apfel SC, Asbury AK, Bril V, Burns TM, Campbell JN, Chalk CH, Dyck PJ, Dyck PJ, Feldman EL, Fields HL, Grant IA, Griffin JW, Klein CJ, Lindblom U, Litchy WJ, Low PA, Melanson M, Mendell JR, Merren MD, O'Brien PC, Rendell M, Rizza RA, Service FJ, Thomas PK, Walk D, Wang AK, Wessel K, Windebank AJ, Ziegler D, Zochodne DW; Ad Hoc Panel on Endpoints for Diabetic Neuropathy Trials.

    J Neurol Sci. 2001 Aug 15;189(1-2):3-5. Review. No abstract available. PMID: 11596565 [PubMed - indexed for MEDLINE]Related articles

    48.

    Status of current clinical trials in diabetic polyneuropathy.

    Bril V.

    Can J Neurol Sci. 2001 Aug;28(3):191-8. Review.PMID: 11513337 [PubMed - indexed for MEDLINE]Related articles

    49.

    Do case series have a role in an evidence-based medical culture?

    Bril V.

    Can J Neurol Sci. 2001 Aug;28(3):189-90. No abstract available. PMID: 11513336 [PubMed - indexed for MEDLINE]Related articles

    50.

    Heart rate variability measurement in diabetic neuropathy: review of methods.

    Risk M, Bril V, Broadbridge C, Cohen A.

    Diabetes Technol Ther. 2001 Spring;3(1):63-76. Review.PMID: 11469709 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...